Tumor-Suppressive Functions of Leucine Zipper Transcription Factor–Like 1
- 31 March 2010
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 70 (7), 2942-2950
- https://doi.org/10.1158/0008-5472.can-09-3826
Abstract
Human leucine zipper transcription factor–like 1 (LZTFL1) is a novel gene with unknown biological functions. It is located in the chromosome region 3p21.3, a hotspot for tumor suppressor genes. To understand the biological functions of LZTFL1, we surveyed the expression level of LZTFL1 in tumor and normal samples in tissue microarrays and a clinical archive of 84 gastric cancer specimens using immunohistochemistry. We found that LZTFL1 is expressed highly in the epithelial cells of normal tissues and is significantly downregulated in the corresponding tumor samples. The expression level of LZTFL1 correlated significantly with the survival outcomes of the patients and had significant inverse correlation with tumor metastasis. Overexpression of LZTFL1 in tumor cells inhibited anchorage-independent cell growth and cell migration in vitro and repressed tumor growth in vivo. Furthermore, we show that LZTFL1 expression is upregulated on epithelial cell differentiation and is graded along the crypt-villus axis of the intestine, with weakest expression level in the proliferative zone of the crypt and highest expression level at the apex of the differentiation zone in the villus. Expression of LZTFL1 overlaps with that of E-cadherin at the plasma membrane. Our results indicate that LZTFL1 is a tumor suppressor and that loss of LZTFL1 expression has significant clinical outcomes. LZTFL1 expression may serve as an independent prognostic marker for survival outcome of gastric cancer patients. We propose that LZTFL1 may inhibit tumorigenesis by stabilizing E-cadherin–mediated adherens junction formation and promoting epithelial cell differentiation. Cancer Res; 70(7); 2942–50Other Versions
This publication has 17 references indexed in Scilit:
- Histone deacetylase inhibitors as a new weapon in the arsenal of differentiation therapies of cancerCancer Letters, 2009
- DNA methylation patterns in lung carcinomasSeminars in Cancer Biology, 2009
- The basics of epithelial-mesenchymal transitionJCI Insight, 2009
- Cadherins and cancer: how does cadherin dysfunction promote tumor progression?Oncogene, 2008
- Evaluation of the 3p21.3 tumour-suppressor gene clusterOncogene, 2007
- Requirement of the enzymatic and signaling activities of plasmin for phorbol-ester-induced scattering of colon cancer cellsExperimental Cell Research, 2006
- Epigenetic Therapy of Cancer With 5-Aza-2′-Deoxycytidine (decitabine)Seminars in Oncology, 2005
- Altered expression of the RON receptor tyrosine kinase in primary human colorectal adenocarcinomas: generation of different splicing RON variants and their oncogenic potentialOncogene, 2003
- The LZTFL1 Gene Is a Part of a Transcriptional Map Covering 250 kb within the Common Eliminated Region 1 (C3CER1) in 3p21.3Genomics, 2001
- Short chain fatty acids in human large intestine, portal, hepatic and venous blood.Gut, 1987